Literature DB >> 25109417

Pterostilbene suppresses oral cancer cell invasion by inhibiting MMP-2 expression.

Chiao-Wen Lin1, Ying-Erh Chou, Hui-Ling Chiou, Mu-Kuan Chen, Wei-En Yang, Ming-Ju Hsieh, Shun-Fa Yang.   

Abstract

OBJECTIVE: Polyphenol compounds, present in a wide variety of natural plants, exhibit antioxidant and free radical scavenging ability and induce apoptosis in various cancer cells. However, the effect of pterostilbene on oral cancer cell metastasis has not been clarified. RESEARCH DESIGN AND METHODS: The present study aimed to examine the anti-metastatic properties of pterostilbene in human oral squamous cell carcinoma (SCC)-9 cells.
RESULTS: In this study, pterostilbene treatment significantly inhibited migration/invasion capacities of SCC-9 cells in vitro. The results of zymography and western blotting revealed that the activities and protein levels of the MMP-2 and urokinase-type plasminogen activator (u-PA) was inhibited by pterostilbene. Western blot analysis also showed that pterostilbene inhibits the phosphorylation of Akt, extracellular signal-regulated kinase 1/2 and p38. Determinations of the mRNA levels, real-time polymerase chain reaction and promoter assays were conducted to evaluate the inhibitory effects of pterostilbene on MMP-2 and u-PA expression in SCC-9 cells. Such inhibitory effects were associated with the upregulation of tissue inhibitor of metalloproteinase-2, plasminogen activator inhibitor-1 and the downregulation of the transcription factors of NF-κB, SP-1 and CREB signaling pathways.
CONCLUSIONS: Pterostilbene may have potential use as a chemopreventive agent against oral cancer metastasis.

Entities:  

Keywords:  MMP-2; migration; oral cancer; pterostilbene; urokinase-type plasminogen activator

Mesh:

Substances:

Year:  2014        PMID: 25109417     DOI: 10.1517/14728222.2014.947962

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  14 in total

1.  Transcriptomic characterization of differential gene expression in oral squamous cell carcinoma: a meta-analysis of publicly available microarray data sets.

Authors:  Yang Sun; Zhijian Sang; Qian Jiang; Xiaojun Ding; Youcheng Yu
Journal:  Tumour Biol       Date:  2016-10-04

2.  Pterostilbene attenuates amyloid-β induced neurotoxicity with regulating PDE4A-CREB-BDNF pathway.

Authors:  Jiao Meng; Yuhua Chen; Fangfang Bi; Hua Li; Cuicui Chang; Wei Liu
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

3.  Genistein Inhibits Aβ25-35-Induced Synaptic Toxicity and Regulates CaMKII/CREB Pathway in SH-SY5Y Cells.

Authors:  Yuan-Di Xi; Dan-Di Zhang; Juan Ding; Huan-Ling Yu; Lin-Hong Yuan; Wei-Wei Ma; Jing Han; Rong Xiao
Journal:  Cell Mol Neurobiol       Date:  2015-12-11       Impact factor: 5.046

4.  High level of plasma matrix metalloproteinase-11 is associated with clinicopathological characteristics in patients with oral squamous cell carcinoma.

Authors:  Chung-Han Hsin; Mu-Kuan Chen; Chih-Hsin Tang; Huang-Pin Lin; Ming-Yung Chou; Chiao-Wen Lin; Shun-Fa Yang
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

5.  Melatonin inhibits TPA-induced oral cancer cell migration by suppressing matrix metalloproteinase-9 activation through the histone acetylation.

Authors:  Chia-Ming Yeh; Chiao-Wen Lin; Jia-Sin Yang; Wei-En Yang; Shih-Chi Su; Shun-Fa Yang
Journal:  Oncotarget       Date:  2016-04-19

6.  Andrographolide suppresses the migratory ability of human glioblastoma multiforme cells by targeting ERK1/2-mediated matrix metalloproteinase-2 expression.

Authors:  Shih-Liang Yang; Fu-Hsuan Kuo; Pei-Ni Chen; Yi-Hsien Hsieh; Nuo-Yi Yu; Wei-En Yang; Ming-Ju Hsieh; Shun-Fa Yang
Journal:  Oncotarget       Date:  2017-11-11

7.  MMP-11 promoted the oral cancer migration and Fak/Src activation.

Authors:  Chung-Han Hsin; Ying-Erh Chou; Shun-Fa Yang; Shih-Chi Su; Yi-Ting Chuang; Shu-Hui Lin; Chiao-Wen Lin
Journal:  Oncotarget       Date:  2017-05-16

Review 8.  Melatonin as a potential inhibitory agent in head and neck cancer.

Authors:  Chia-Ming Yeh; Shih-Chi Su; Chiao-Wen Lin; Wei-En Yang; Ming-Hsien Chien; Russel J Reiter; Shun-Fa Yang
Journal:  Oncotarget       Date:  2017-08-09

9.  Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine.

Authors:  Xuanbin Wang; Ning Wang; Hongliang Li; Ming Liu; Fengjun Cao; Xianjun Yu; Jingxuan Zhang; Yan Tan; Longchao Xiang; Yibin Feng
Journal:  Int J Mol Sci       Date:  2016-04-16       Impact factor: 5.923

10.  Potential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and Colchicine.

Authors:  Saurabh Bundela; Anjana Sharma; Prakash S Bisen
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.